PCM
Penserra Capital Management Portfolio holdings
AUM
$7.17B
1-Year Return
49.58%
This Quarter Return
+9.42%
1 Year Return
+49.58%
3 Year Return
+118.16%
5 Year Return
+229.83%
10 Year Return
–
AUM
$5.41B
AUM Growth
+$1.18B
(+28%)
Cap. Flow
+$972M
Cap. Flow
% of AUM
17.96%
Top 10 Holdings %
Top 10 Hldgs %
20.49%
Holding
1,158
New
152
Increased
697
Reduced
246
Closed
52
Top Buys
| 1 |
Alibaba
BABA
|
$59.8M |
| 2 |
JD.com
JD
|
$41.3M |
| 3 |
Mercado Libre
MELI
|
$35.1M |
| 4 |
NetEase
NTES
|
$34.7M |
| 5 |
KE Holdings
BEKE
|
$19.5M |
Top Sells
| 1 |
Futu Holdings
FUTU
|
$27.8M |
| 2 |
Trip.com Group
TCOM
|
$21.9M |
| 3 |
AOD
abrdn Total Dynamic Dividend Fund
AOD
|
$12.1M |
| 4 |
Gabelli Dividend & Income Trust
GDV
|
$12M |
| 5 |
EFR
Eaton Vance Senior Floating-Rate Fund
EFR
|
$11.2M |
Sector Composition
| 1 | Consumer Discretionary | 33.74% |
| 2 | Technology | 22.72% |
| 3 | Communication Services | 13.35% |
| 4 | Industrials | 4.85% |
| 5 | Real Estate | 4.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
951
Lithia Motors
LAD
$8.74B
| $23K | ﹤0.01% |
61
+8
| +15% | +$3.02K |
|
952
Regency Centers
REG
$13.4B
| $23K | ﹤0.01% |
419
+64
| +18% | +$3.51K |
|
953
Sunrun
RUN
$4.19B
| $23K | ﹤0.01% |
382
+61
| +19% | +$3.67K |
|
954
Rhythm Pharmaceuticals
RYTM
$6.78B
| $23K | ﹤0.01% |
1,110
+95
| +9% | +$1.97K |
|
955
Toronto Dominion Bank
TD
$127B
| $23K | ﹤0.01% |
363
+242
| +200% | +$15.3K |
|
|
Y
956
DELISTED
Alleghany Corporation
Y
| $23K | ﹤0.01% |
38
+8
| +27% | +$4.84K |
|
957
Akero Therapeutics
AKRO
$3.58B
| $22K | ﹤0.01% |
790
-5
| -0.6% | -$139 |
|
958
Enanta Pharmaceuticals
ENTA
$189M
| $22K | ﹤0.01% |
460
-5
| -1% | -$239 |
|
959
MannKind Corp
MNKD
$1.7B
| $22K | ﹤0.01% |
5,620
+285
| +5% | +$1.12K |
|
960
Vaxcyte
PCVX
$4.29B
| $22K | ﹤0.01% |
1,150
-30
| -3% | -$574 |
|
961
Prothena Corp
PRTA
$460M
| $22K | ﹤0.01% |
900
-15
| -2% | -$367 |
|
|
GTHX
962
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $22K | ﹤0.01% |
945
+70
| +8% | +$1.63K |
|
|
RDUS
963
DELISTED
Radius Health, Inc.
RDUS
| $22K | ﹤0.01% |
1,060
-25
| -2% | -$519 |
|
964
Adverum Biotechnologies
ADVM
$73.9M
| $21K | ﹤0.01% |
221
-3
| -1% | -$285 |
|
|
AFMD
965
DELISTED
Affimed
AFMD
| $20K | ﹤0.01% |
261
+50
| +24% | +$3.83K |
|
|
IMAB
966
I-MAB
IMAB
$358M
| $20K | ﹤0.01% |
420
+60
| +17% | +$2.86K |
|
967
Omega Healthcare
OHI
$12.7B
| $20K | ﹤0.01% |
566
+88
| +18% | +$3.11K |
|
968
Oric Pharmaceuticals
ORIC
$1.06B
| $20K | ﹤0.01% |
825
-15
| -2% | -$364 |
|
969
Passage Bio
PASG
$22.8M
| $20K | ﹤0.01% |
60
+8
| +15% | +$2.67K |
|
970
Reinsurance Group of America
RGA
$12.8B
| $20K | ﹤0.01% |
166
+24
| +17% | +$2.89K |
|
971
Vornado Realty Trust
VNO
$7.93B
| $20K | ﹤0.01% |
451
+72
| +19% | +$3.19K |
|
|
PETQ
972
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $20K | ﹤0.01% |
570
-10
| -2% | -$351 |
|
|
EPZM
973
DELISTED
Epizyme, Inc
EPZM
| $20K | ﹤0.01% |
2,300
-30
| -1% | -$261 |
|
|
VER
974
DELISTED
VEREIT, Inc.
VER
| $20K | ﹤0.01% |
534
+80
| +18% | +$3K |
|
975
Amphastar Pharmaceuticals
AMPH
$1.37B
| $19K | ﹤0.01% |
1,070
-20
| -2% | -$355 |
|